
The Binaytara Precision Oncology Research Awards support emerging investigators driving innovation in precision oncology, genomics, and targeted cancer therapies. Presented at the 6th Binaytara Precision Oncology Summit, these awards aim to accelerate research that translates molecular insights into improved patient outcomes.
Two competitive awards will be granted to outstanding early-career investigators whose work demonstrates scientific merit, clinical relevance, and potential impact on the future of cancer care.
** Award Amount: Two awards of $25,000 each
Projects should align with the principles of precision oncology and molecular targeted strategies, including:
Applicants must submit or be listed as an author on an abstract (completed or ongoing research) submitted to the 6th Binaytara Precision Oncology Summit. Submit your abstract by July 15, 2026
Selected finalists will present their proposals live during Binaytara’s signature Impact Pitch Session—a one-of-its-kind, Shark Tank–inspired research competition where finalists present their ideas live before expert judges.
This high-visibility session highlights bold, innovative concepts and provides a unique platform for emerging leaders in oncology research to gain recognition and feedback from national experts.
Applicants must meet all of the following criteria:
This award offers a unique opportunity to secure funding, gain national visibility, and showcase your ideas at a leading precision oncology conference. Through participation in the Impact Pitch Session, applicants gain exposure to expert judges, peer researchers, and potential collaborators while contributing to the advancement of molecularly targeted cancer care.